Keyphrases
Older Adults
100%
Late-life Depression
57%
Later Life
29%
Major Depressive Disorder
27%
Antidepressants
24%
Depressive Symptoms
23%
Generalized Anxiety Disorder
20%
Hip Fracture
19%
Randomized Controlled Trial
18%
Anxiety Disorders
18%
Remission
17%
Venlafaxine
17%
Placebo
17%
Clinical Trials
15%
Treatment-resistant Depression
15%
Selective Serotonin Reuptake Inhibitors
14%
Pharmacotherapy
13%
Randomized Clinical Trial
13%
Aripiprazole
12%
Elderly People
11%
Antidepressant Treatment
11%
Anxiety Symptoms
10%
Cognitive Impairment
10%
Escitalopram
9%
Late-life Anxiety
9%
Ecological Momentary Assessment
9%
Mindfulness-based Stress Reduction
9%
Treatment Outcome
9%
Executive Function
9%
COVID-19
9%
Confidence Interval
9%
Functional Recovery
8%
Treatment-resistant
8%
Depression Treatment
7%
Older Patients
7%
Mental Health Care
7%
Functional Outcome
7%
Tolerability
7%
Fluvoxamine
6%
Disability
6%
Anxiety-depression
6%
Treatment Response
6%
Mental Health
6%
Mindfulness Training
6%
Depression in Elderly
6%
Comorbid Anxiety
6%
Depression Severity
6%
Bupropion
6%
D-cycloserine
6%
Postoperative Delirium
6%
Medicine and Dentistry
Late Life Depression
23%
Antidepressant
15%
Randomized Controlled Trial
14%
Depressive Disorder
13%
Clinical Trial
12%
Placebo
11%
Aripiprazole
10%
Mental Health
10%
Randomized Clinical Trial
10%
Treatment Resistant Depression
10%
Drug Therapy
9%
Major Depressive Episode
8%
COVID-19
8%
Venlafaxine
7%
Hip Fracture
6%
Postoperative Delirium
6%
Cognitive Defect
6%
Executive Function
6%
Quality of Life
6%
Anxiety Disorder
6%
Geriatrics
5%
Ketamine
5%
Generalized Anxiety Disorder
5%
Escitalopram
5%